Here's the line-up of experts for Tech Founders for Garvan, it's second to none. We hope that you can join us.
Prof Chris Goodnow
Chris Goodnow is the Executive Director of Garvan Institute of Medical Research. Chris is an internationally renowned immunologist. He joined Garvan in 2015 and is best known for integrating molecular genetics and genomics with immunology, for which he received numerous awards and election to the Australian Academy of Science, the UK Royal Society, and the US National Academy of Science.
Mr Scott Farquhar
Scott Farquhar is the co-founder and co-CEO of Atlassian. Scott was awarded the ‘Australian IT Professional of the Year’ in 2004, and in 2006 was the youngest person ever to be awarded the ‘Australian Entrepreneur of the Year’ by Ernst & Young alongside co-founder and co-CEO Mike Cannon-Brookes.
Mr Nick Abrahams
Nick Abrahams is the Global Head of Technology and Innovation at Norton Rose Fulbright and has deep commercial expertise and global networks in the technology space. He is the Founder of leading online legal site, LawPath. He is a non-executive director on ASX300 software company, Integrated Research.
A/Prof Daniel MacArthur
Newly recruited to the Garvan Institute, Daniel MacArthur was an Institute member of is an institute member at the Broad Institute of MIT and Harvard, and co-director of the Broad’s Program in Medical and Population Genetics. Daniel's work revolves around the use of large-scale genomic data to interpret genetic variants, particularly in the context of rare, severe genetic diseases.
A/Prof Joseph Powell
Joseph Powell is the head of the Garvan Weizmann Centre for Cellular Genomics, a Lab head at the Garvan Institute of Medical Research, and a Principal Research Fellow in the Faculty of Medicine, University of New South Wales.
A/Prof Sarah Kummerfeld
Sarah Kummerfeld is the Scientific Head of the Kinghorn Centre for Clinical Genomics. She uses genomics to understand human disease and translate findings into clinical diagnostics and treatments. Sarah completed her PhD in Computational Biology at the University of Cambridge, working on protein structure and function prediction.
Mr David Barda
David Barda is an entrepreneur, executive and advisor specialising in technology commercialisation and early-stage ventures for biomedical technologies. David heads up business development and innovation at the Garvan Institute of Medical Research, that leads the world with its work in the areas of genomics, bioinformatics, cancer, and immunology.
